Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly IV Estramustine + Paclitaxel + Carboplatin in Advanced Prostate Cancer
NCT00003394Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 1998
- Primary completion
- Apr 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of estramustine in prostate cancer (PCa), sponsored by Memorial Sloan Kettering Cancer Center. Started Apr 1998; status: completed.
02
Drugs
estramustine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003394.